Neurological complications of infliximab.
Tektonidou
Maria G
MG
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D016472:Motor Neuron Disease / Q000175:diagnosis / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis / Q000209:etiology*; D012216:Rheumatic Diseases / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab